Katie King, cofounder and CEO of BioOrbit, discussed the company's recent milestone in producing protein crystals in space. BioOrbit launched a record-breaking mission to the International Space Station, achieving the largest scale production of protein crystals in a microgravity environment by one to two orders of magnitude. King spoke to Bloomberg's Tom Mackenzie. (Source: Bloomberg)
Katie King, cofounder and CEO of BioOrbit, discussed the company's recent milestone in producing protein crystals in space. BioOrbit launched a record-breaking mission to the International Space Station, achieving the largest scale production of protein crystals in a microgravity environment by one to two orders of magnitude. King spoke to Bloomberg's Tom Mackenzie. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/b02ff6cd17b2e4dee86f39d4dc371a3339ae6f04" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="BioOrbit CEO on Developing Cancer Treatments in Zero Gravity"></iframe>
